All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Bioequivalence of two brands of citalopram 40 mg tablets after single oral administration to healthy volunteers.

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15110%2F05%3A00001967" target="_blank" >RIV/61989592:15110/05:00001967 - isvavai.cz</a>

  • Result on the web

  • DOI - Digital Object Identifier

Alternative languages

  • Result language

    angličtina

  • Original language name

    Bioequivalence of two brands of citalopram 40 mg tablets after single oral administration to healthy volunteers.

  • Original language description

    A randomized, two-way, crossover, bioequivalence study was conducted in 26 fasting, healthy, male volunteers tocompare two brands of citalopram 40 mg tablets, Citol (Abdi Ibrahim &#304;laç San. ve Tic A.Ş., Istanbul, Turkey) as a testand Cipramil(R) (H.Lundbeck A/S, Copenhagen, Denmark) as a reference product. One tablet of either formulationwas administered with low-carbonate water after 10 h of overnight fasting. After dosing, serial blood samples werecollected during a period of 24 hours. Plasma samples were analysed for citalopram by a validated HPLC method.The pharmacokinetic parameters AUC0-24, AUC0-&#945;, Cmax, Tmax, Kel, T1/2, and CL were determined from plasma concentration-time pro&#64257;les for both formulations and were compared statistically to evaluate bioequivalence between thetwo brands of citalopram, using the statistical modules recommended by FDA. The analysis of variance (ANOVA)did not show any signi&#64257;cant di&#64256;erence between the two formulations a

  • Czech name

    Bioekvivalence dvou značek citalopramu 40mg tbl. po jedné orální davce na zdravých dobrovolnících.

  • Czech description

    Tato dvojfázová, zkřížená studie založená na opakovaném podávání léku zdravým dobrovolníkům s cílem stanovit bioekvivalenci (podobnost) dvou lékových forem pro perorální (ústní) podání obsahujících 40 mg citalopramu v jedné tabletě, a to Citol (Abdi Ibrahim &#304;laç San. ve Tic A.Ş., Istanbul, Turkey a Cipramil(R) (H. Lundbeck A/S, Copenhagen, Denmark) jako referenční produkt.

Classification

  • Type

    J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

  • CEP classification

    FR - Pharmacology and apothecary chemistry

  • OECD FORD branch

Result continuities

  • Project

  • Continuities

    Z - Vyzkumny zamer (s odkazem do CEZ)

Others

  • Publication year

    2005

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Biomedical Papers

  • ISSN

    1213-8118

  • e-ISSN

  • Volume of the periodical

    149

  • Issue of the periodical within the volume

    1

  • Country of publishing house

    CZ - CZECH REPUBLIC

  • Number of pages

    4

  • Pages from-to

    169-172

  • UT code for WoS article

  • EID of the result in the Scopus database